Schoemaker H - Search Results

1

SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.

Griebel G, Perrault G, Simiand J, Cohen C, Granger P, Decobert M, Françon D, Avenet P, Depoortere H, Tan S, Oblin A, Schoemaker H, Evanno Y, Sevrin M, George P, Scatton B. Griebel G, et al. Among authors: schoemaker h. J Pharmacol Exp Ther. 2001 Aug;298(2):753-68. J Pharmacol Exp Ther. 2001. PMID: 11454940

2

SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms.

Griebel G, Perrault G, Simiand J, Cohen C, Granger P, Depoortere H, Françon D, Avenet P, Schoemaker H, Evanno Y, Sevrin M, George P, Scatton B. Griebel G, et al. Among authors: schoemaker h. CNS Drug Rev. 2003 Spring;9(1):3-20. doi: 10.1111/j.1527-3458.2003.tb00241.x. CNS Drug Rev. 2003. PMID: 12595909 Free PMC article. Review.

3

Discriminative stimulus effects of drugs acting at GABA(A) receptors: differential profiles and receptor selectivity.

Sanger DJ, Griebel G, Perrault G, Claustre Y, Schoemaker H. Sanger DJ, et al. Among authors: schoemaker h. Pharmacol Biochem Behav. 1999 Oct;64(2):269-73. doi: 10.1016/s0091-3057(99)00081-7. Pharmacol Biochem Behav. 1999. PMID: 10515302 Review.

4

Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands.

Griebel G, Perrault G, Tan S, Schoemaker H, Sanger DJ. Griebel G, et al. Among authors: schoemaker h. Behav Pharmacol. 1999 Sep;10(5):483-95. doi: 10.1097/00008877-199909000-00007. Behav Pharmacol. 1999. PMID: 10780255

5

SL 84.0418: a novel, potent and selective alpha-2 adrenoceptor antagonist: in vitro pharmacological profile.

Angel I, Schoemaker H, Arbilla S, Galzin AM, Berry C, Niddam R, Pimoule C, Sevrin M, Wick A, Langer SZ. Angel I, et al. Among authors: schoemaker h. J Pharmacol Exp Ther. 1992 Dec;263(3):1327-33. J Pharmacol Exp Ther. 1992. PMID: 1281878

6

Complex allosteric modulation of the binding of the NMDA receptor antagonist [3H]CGP39653.

Oblin A, Schoemaker H. Oblin A, et al. Among authors: schoemaker h. Eur J Pharmacol. 1994 Jan 1;266(1):103-6. doi: 10.1016/0922-4106(94)90215-1. Eur J Pharmacol. 1994. PMID: 7907987

7

[The place of amisulpride in the atypical neuroleptic class].

Perrault G, Schoemaker H, Scatton B. Perrault G, et al. Among authors: schoemaker h. Encephale. 1996 Jun;22 Spec No 2:3-8. Encephale. 1996. PMID: 8767034 Review. French.

8

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.

Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B. Schoemaker H, et al. J Pharmacol Exp Ther. 1997 Jan;280(1):83-97. J Pharmacol Exp Ther. 1997. PMID: 8996185

9

Pharmacological studies on synthetic flavonoids: comparison with diazepam.

Griebel G, Perrault G, Tan S, Schoemaker H, Sanger DJ. Griebel G, et al. Among authors: schoemaker h. Neuropharmacology. 1999 Jul;38(7):965-77. doi: 10.1016/s0028-3908(99)00026-x. Neuropharmacology. 1999. PMID: 10428415

10

New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.

Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H, Sanger DJ. Griebel G, et al. Among authors: schoemaker h. Psychopharmacology (Berl). 1999 Sep;146(2):205-13. doi: 10.1007/s002130051108. Psychopharmacology (Berl). 1999. PMID: 10525757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters